- Home
- AUTL vs NKX Comparison
AUTL vs NKX Comparison
Compare AUTL & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- NKX
- Stock Information
- Founded
- AUTL 2014
- NKX 2002
- Country
- AUTL United Kingdom
- NKX United States
- Employees
- AUTL N/A
- NKX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- NKX Finance/Investors Services
- Sector
- AUTL Health Care
- NKX Finance
- Exchange
- AUTL Nasdaq
- NKX Nasdaq
- Market Cap
- AUTL 609.4M
- NKX 599.7M
- IPO Year
- AUTL 2018
- NKX N/A
- Fundamental
- Price
- AUTL $2.21
- NKX $12.68
- Analyst Decision
- AUTL Strong Buy
- NKX
- Analyst Count
- AUTL 3
- NKX 0
- Target Price
- AUTL $10.20
- NKX N/A
- AVG Volume (30 Days)
- AUTL 1.7M
- NKX 109.3K
- Earning Date
- AUTL 11-12-2024
- NKX 01-01-0001
- Dividend Yield
- AUTL N/A
- NKX 4.37%
- EPS Growth
- AUTL N/A
- NKX N/A
- EPS
- AUTL N/A
- NKX N/A
- Revenue
- AUTL $10,091,000.00
- NKX N/A
- Revenue This Year
- AUTL $851.83
- NKX N/A
- Revenue Next Year
- AUTL $264.18
- NKX N/A
- P/E Ratio
- AUTL N/A
- NKX N/A
- Revenue Growth
- AUTL 82.71
- NKX N/A
- 52 Week Low
- AUTL $2.07
- NKX $9.78
- 52 Week High
- AUTL $7.37
- NKX $12.00
- Technical
- Relative Strength Index (RSI)
- AUTL 35.87
- NKX 47.91
- Support Level
- AUTL $2.17
- NKX $12.42
- Resistance Level
- AUTL $2.80
- NKX $12.76
- Average True Range (ATR)
- AUTL 0.17
- NKX 0.25
- MACD
- AUTL 0.02
- NKX 0.01
- Stochastic Oscillator
- AUTL 19.18
- NKX 63.93
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.